Literature DB >> 14367514

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.

O D RATNOFF, J E COLOPY.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS/complications

Mesh:

Year:  1955        PMID: 14367514      PMCID: PMC438666          DOI: 10.1172/JCI103109

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  A possible fourth plasma thromboplastin component.

Authors:  T H SPAET; P M AGGELER; B G KINSELL
Journal:  J Clin Invest       Date:  1954-08       Impact factor: 14.808

2.  Purification and isolation of certain intermediates formed prior to the activation of prothrombin.

Authors:  J E FLYNN; R W COON
Journal:  Am J Physiol       Date:  1953-11

3.  Christmas disease: a condition previously mistaken for haemophilia.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE; J V DACIE; W R PITNEY
Journal:  Br Med J       Date:  1952-12-27

4.  New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

Authors:  R L ROSENTHAL; O H DRESKIN; N ROSENTHAL
Journal:  Proc Soc Exp Biol Med       Date:  1953-01

5.  THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN".

Authors:  C L Conley; R C Hartmann; W I Morse
Journal:  J Clin Invest       Date:  1949-03       Impact factor: 14.808

6.  Isolation and properties of the third clotting factor in blood-platelets.

Authors:  S VAN CREVELD; M M PAULSSEN; R VONK
Journal:  Lancet       Date:  1952-01-05       Impact factor: 79.321

7.  The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma.

Authors:  O D RATNOFF; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1951-09

8.  Proteolytic enzymes and platelets in relation to blood coagulation.

Authors:  B L TRAVIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1951-01       Impact factor: 14.808

9.  Studies on the initiation of blood coagulation. II. An anticoagulant inhibiting the activation of a plasma thromboplastic factor.

Authors:  C L COLNEY; O D RATNOFF; C E ELLICOTT; R C HARTMANN
Journal:  J Clin Invest       Date:  1950-09       Impact factor: 14.808

10.  Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor.

Authors:  I SCHULMAN; C H SMITH
Journal:  Blood       Date:  1952-08       Impact factor: 22.113

View more
  106 in total

1.  Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF-ET and coagulation factor XI deficiency: a case report.

Authors:  C Battaglia; G Regnani; S Giulini; L Madgar; A D Genazzani; A Volpe
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

2.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

Review 3.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

Review 4.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

5.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

6.  THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

Authors:  O D RATNOFF; A A MILES
Journal:  Br J Exp Pathol       Date:  1964-06

7.  THE CLOT-PROMOTING EFFECT OF SOAPS OF LONG-CHAIN SATURATED FATTY ACIDS.

Authors:  R E BOTTI; O D RATNOFF
Journal:  J Clin Invest       Date:  1963-10       Impact factor: 14.808

8.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

9.  The inflammatory response.

Authors:  W G SPECTOR; D A WILLOUGHBY
Journal:  Bacteriol Rev       Date:  1963-06

10.  Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitution.

Authors:  T Miyata; S Kawabata; S Iwanaga; I Takahashi; B Alving; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.